Medicines and Poisons (Medicines) Regulation 2021
sec.237Chief executive may approve alternative ways of labelling or packaging medicines
Start here
Get a plain-English read of sec.237
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sec.237 Chief executive may approve alternative ways of labelling or packaging medicines
The chief executive may approve a way (an alternative way ) of labelling or packaging a medicine that is different to the Poisons Standard. However, the chief executive may approve the alternative way only if the chief executive is satisfied it is unlikely to adversely affect public safety, having regard to the nature of the medicine and the purpose for which it is to be used. The chief executive must publish, on the department’s website, a notice stating— the requirements of the alternative way; and the day, no earlier than the day the notice is published, that the approval of the alternative way takes effect; and the period, if any, for which the approval of the alternative way has effect. Subsection (5) applies if an appropriate authority, for a purpose or in another State, has authorised (whether by approval, exemption or some other way) another way to label or package a medicine for the purpose or other State. See the Poisons Standard, section 6 for the definition appropriate authority . To the extent authorised by the appropriate authority, the other way is taken to be an alternative way approved under this section, unless the chief executive publishes a notice on the department’s website stating the other way is not approved for Queensland. s 237 amd 2023 SL No. 170 s 7 (sec.237-ssec.1) The chief executive may approve a way (an alternative way ) of labelling or packaging a medicine that is different to the Poisons Standard. (sec.237-ssec.2) However, the chief executive may approve the alternative way only if the chief executive is satisfied it is unlikely to adversely affect public safety, having regard to the nature of the medicine and the purpose for which it is to be used. (sec.237-ssec.3) The chief executive must publish, on the department’s website, a notice stating— the requirements of the alternative way; and the day, no earlier than the day the notice is published, that the approval of the alternative way takes effect; and the period, if any, for which the approval of the alternative way has effect. (sec.237-ssec.4) Subsection (5) applies if an appropriate authority, for a purpose or in another State, has authorised (whether by approval, exemption or some other way) another way to label or package a medicine for the purpose or other State. See the Poisons Standard, section 6 for the definition appropriate authority . (sec.237-ssec.5) To the extent authorised by the appropriate authority, the other way is taken to be an alternative way approved under this section, unless the chief executive publishes a notice on the department’s website stating the other way is not approved for Queensland.
- (a) the requirements of the alternative way; and
- (b) the day, no earlier than the day the notice is published, that the approval of the alternative way takes effect; and